SDR16C6, which stands for "Short Chain Dehydrogenase/Reductase Family 16C, Member 6," is part of the SDR family of enzymes. It is characterized by its role in oxidoreduction reactions where it catalyzes the NAD(P)(H)-dependent oxidation or reduction of substrates with a relatively short-chain length. SDR16C6, like other members of the SDR family, is involved in a myriad of metabolic processes which can include the metabolism of steroids, fatty acids, and xenobiotics.The SDR enzymes are known for their conserved structural motif, often referred to as the Rossmann fold, which is essential for binding the coenzyme NAD(P)(H). This motif is a key feature that allows these enzymes to participate in the electron transfer required for their catalytic activity. The precise function of SDR16C6, in terms of its specific substrates and biological roles, is not as well characterized as other members of the SDR family.
Nevertheless, the enzymatic activity of SDR16C6 suggests it may play a role in the metabolism of hormones or signaling molecules, contributing to the regulation of various physiological pathways. Changes in the expression or activity of SDR16C6 could feasibly influence metabolic balance, and an understanding of its function might shed light on certain metabolic disorders or contribute to the development of drugs targeting specific metabolic pathways.It's also important to note that SDR enzymes, in general, can be subject to regulation by various cellular factors and might be involved in the cellular response to external stimuli, including drugs and environmental factors. As such, SDR16C6 may also be part of the broader network of enzymes that help maintain cellular homeostasis by modulating metabolic pathways in response to changing cellular needs and conditions.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Metformin | 657-24-9 | sc-507370 | 10 mg | $79.00 | 2 | |
An antidiabetic drug that modulates glucose metabolism, potentially influencing pathways related to SDR16C6. | ||||||
Insulin | 11061-68-0 | sc-29062 sc-29062A sc-29062B | 100 mg 1 g 10 g | $156.00 $1248.00 $12508.00 | 82 | |
As a key regulator of glucose and lipid metabolism, insulin could indirectly affect SDR16C6 activity. | ||||||
Pioglitazone | 111025-46-8 | sc-202289 sc-202289A | 1 mg 5 mg | $55.00 $125.00 | 13 | |
A PPARγ agonist, influences lipid and glucose metabolism, potentially impacting SDR16C6. | ||||||
Rosiglitazone | 122320-73-4 | sc-202795 sc-202795A sc-202795C sc-202795D sc-202795B | 25 mg 100 mg 500 mg 1 g 5 g | $120.00 $326.00 $634.00 $947.00 $1259.00 | 38 | |
Another PPARγ agonist, alters lipid and glucose metabolism, which could affect SDR16C6. | ||||||
Acarbose | 56180-94-0 | sc-203492 sc-203492A | 1 g 5 g | $226.00 $605.00 | 1 | |
An alpha-glucosidase inhibitor, affects carbohydrate metabolism, potentially influencing SDR16C6. | ||||||
Fenofibrate | 49562-28-9 | sc-204751 | 5 g | $41.00 | 9 | |
As a PPARα agonist, fenofibrate modulates lipid metabolism, potentially affecting SDR16C6. | ||||||
Nicotinic Acid | 59-67-6 | sc-205768 sc-205768A | 250 g 500 g | $62.00 $124.00 | 1 | |
Influences lipid metabolism, potentially impacting SDR16C6-related pathways. | ||||||
Atorvastatin | 134523-00-5 | sc-337542A sc-337542 | 50 mg 100 mg | $257.00 $505.00 | 9 | |
A statin that affects cholesterol metabolism, potentially impacting SDR16C6. | ||||||
Lipase Inhibitor, THL | 96829-58-2 | sc-203108 | 50 mg | $52.00 | 7 | |
Inhibits lipase, impacting lipid digestion and absorption, potentially influencing SDR16C6. | ||||||